Area of research
Oncology · Cancer Research
Research interest
Research interests include Medicine, Periampullary cancer, Pathological, Pathology, Randomized controlled trial, and Internal medicine.
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial
Dataset related to article "The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial."
Dataset related to article "The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial."
Dataset related to article "The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial."
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer
Reelin expression in human liver of patients with chronic hepatitis C infection
HER2 Status in Gastric Cancer: Comparison between Primary and Distant Metastatic Disease
A Feasible Flowchart to Screen EBV-Positive Diffuse Large B Cell Lymphoma of the elderly: A Molecular Approach
Annals of Pathology and Laboratory Medicine 2016cited by 0position: middle
Incidence and prognostic impact of para‐aortic lymph nodes metastases during pancreaticoduodenectomy for peri‐ampullary cancer
Microscopic Residual Tumor After Pancreaticoduodenectomy
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs)
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs).
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer
<i>HER2</i> amplification status in gastric and gastro‐oesophageal junction cancer in routine clinical practice: which sample should be used?
Desmoid tumor occurrence in female siblings not associated with familial adenomatous polyposis: genetic or sporadic form?